Announcements Trials
Browse Landscape

Status

Recruiting 5Unknown 4Completed 4Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Uveal Melanoma 1Peutz-Jeghers Syndrome 1Pancreatitis, Chronic 1Pancreatic Neoplasms 1Pancreatic Cyst 1Non-small Cell Lung Cancer Metastatic 1Neoplasms 1Neoplasm Metastasis 1Lymphoma 1Leukemia 1Hip Fractures 1Fractures, Spontaneous 1Dysplastic Nevus Syndrome 1Colorectal Neoplasms, Hereditary Nonpolyposis 1COVID-19 1Breast Neoplasms 1Ataxia Telangiectasia 1

Interventions

pembrolizumab 26Cyclophosphamide 20Nivolumab 14Doxorubicin 13Surveys and Questionnaires 9Exercise 9Carboplatin 9atezolizumab 8Vincristine 8Rituximab 8Radiotherapy 8Prednisone 8Paclitaxel 8Dexamethasone 8Bevacizumab 8venetoclax 7fludarabine 7Fluorouracil 7Docetaxel 7Blood Specimen Collection 7lenvatinib 6dostarlimab 6cemiplimab 6budigalimab 6Pemetrexed 6Oxaliplatin 6Cisplatin 6durvalumab 5Leucovorin 5Lenalidomide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Neoplasms × Data Collection × Clear all
NCT02159742 2025-07-02

Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases

Abramson Cancer Center at Penn Medicine

Active not recruiting
400 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡